Cannapharmarx Stock Performance
| CPMD Stock | USD 0 0.0002 4.76% |
CannaPharmaRx holds a performance score of 6 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.89, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning CannaPharmaRx are expected to decrease slowly. On the other hand, during market turmoil, CannaPharmaRx is expected to outperform it slightly. Use CannaPharmaRx total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to analyze future returns on CannaPharmaRx.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CannaPharmaRx are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, CannaPharmaRx exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 335 K | |
| Total Cashflows From Investing Activities | 533.1 K |
CannaPharmaRx |
CannaPharmaRx Relative Risk vs. Return Landscape
If you would invest 0.50 in CannaPharmaRx on October 31, 2025 and sell it today you would lose (0.10) from holding CannaPharmaRx or give up 20.0% of portfolio value over 90 days. CannaPharmaRx is currently generating 2.1707% in daily expected returns and assumes 24.9029% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than CannaPharmaRx, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CannaPharmaRx Target Price Odds to finish over Current Price
The tendency of CannaPharmaRx Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0 | 90 days | 0 | about 71.55 |
Based on a normal probability distribution, the odds of CannaPharmaRx to move above the current price in 90 days from now is about 71.55 (This CannaPharmaRx probability density function shows the probability of CannaPharmaRx Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days CannaPharmaRx has a beta of -0.89 suggesting In addition to that CannaPharmaRx has an alpha of 2.117, implying that it can generate a 2.12 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). CannaPharmaRx Price Density |
| Price |
Predictive Modules for CannaPharmaRx
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CannaPharmaRx. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.CannaPharmaRx Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CannaPharmaRx is not an exception. The market had few large corrections towards the CannaPharmaRx's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CannaPharmaRx, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CannaPharmaRx within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 2.12 | |
β | Beta against Dow Jones | -0.89 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.08 |
CannaPharmaRx Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CannaPharmaRx for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CannaPharmaRx can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CannaPharmaRx is way too risky over 90 days horizon | |
| CannaPharmaRx has some characteristics of a very speculative penny stock | |
| CannaPharmaRx appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (8.83 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CannaPharmaRx currently holds about 5.18 K in cash with (2.41 M) of positive cash flow from operations. |
CannaPharmaRx Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CannaPharmaRx Pink Sheet often depends not only on the future outlook of the current and potential CannaPharmaRx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CannaPharmaRx's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 40.7 M | |
| Cash And Short Term Investments | 27.8 K |
CannaPharmaRx Fundamentals Growth
CannaPharmaRx Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CannaPharmaRx, and CannaPharmaRx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CannaPharmaRx Pink Sheet performance.
| Return On Equity | -2.51 | |||
| Return On Asset | -0.26 | |||
| Current Valuation | 20.13 M | |||
| Shares Outstanding | 257.57 M | |||
| Price To Book | 11.05 X | |||
| EBITDA | (6.07 M) | |||
| Cash And Equivalents | 5.18 K | |||
| Total Debt | 14.96 M | |||
| Debt To Equity | 7.05 % | |||
| Book Value Per Share | (0.07) X | |||
| Cash Flow From Operations | (2.41 M) | |||
| Earnings Per Share | (0.12) X | |||
| Total Asset | 114.33 K | |||
| Retained Earnings | (28.64 M) | |||
| Current Asset | 233 K | |||
| Current Liabilities | 518 K | |||
About CannaPharmaRx Performance
By analyzing CannaPharmaRx's fundamental ratios, stakeholders can gain valuable insights into CannaPharmaRx's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CannaPharmaRx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CannaPharmaRx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CannaPharmaRX, Inc. operates in the cannabis industry in Canada. The company was incorporated in 1998 and is based in Calgary, Canada. Cannapharmarx operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.Things to note about CannaPharmaRx performance evaluation
Checking the ongoing alerts about CannaPharmaRx for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CannaPharmaRx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CannaPharmaRx is way too risky over 90 days horizon | |
| CannaPharmaRx has some characteristics of a very speculative penny stock | |
| CannaPharmaRx appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (8.83 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CannaPharmaRx currently holds about 5.18 K in cash with (2.41 M) of positive cash flow from operations. |
- Analyzing CannaPharmaRx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CannaPharmaRx's stock is overvalued or undervalued compared to its peers.
- Examining CannaPharmaRx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CannaPharmaRx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CannaPharmaRx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CannaPharmaRx's pink sheet. These opinions can provide insight into CannaPharmaRx's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CannaPharmaRx Pink Sheet analysis
When running CannaPharmaRx's price analysis, check to measure CannaPharmaRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannaPharmaRx is operating at the current time. Most of CannaPharmaRx's value examination focuses on studying past and present price action to predict the probability of CannaPharmaRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannaPharmaRx's price. Additionally, you may evaluate how the addition of CannaPharmaRx to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |